Date:5/1/2012

ses.  The Company believes that these non-GAAP financial measures provide investors with insight into what is used by management to conduct a more meaningful and consistent comparison of the Company's ongoing operating results and trends, compared with historical results.  This presentation is also consistent with the measures management uses to measure the performance of ongoing operating results against prior periods and against our internally developed targets.  There are limitations in using these non-GAAP financial measures because they are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies.  These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial measures.  Investors and potential investors should consider non-GAAP financial measures only in conjunction with the Company's consolidated financial statements prepared in accordance with GAAP and the reconciliation of non-GAAP financial measures attached to this release.

Conference Call Information The Company will also host a conference call and webcast today, Tuesday, May 1, 2012, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate developments.  The dial-in number for the conference call is 877-941-6010 for domestic participants and 480-629-9770 for international participants.

To access the live webcast of the call, go to Solta Medical's website at www.solta.com and click on Investor Relations. An archived webcast will also be available at www.solta.com.

About Solta Medical, Inc.Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic en
'/>"/>

SOURCE Solta Medical, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Solta Medical to Report First Quarter 2012 Results Release and Host Conference Call on May 1
2. Solta Medical Provides Update on Liposonix Launch
3. Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System
4. Solta Medical Reports Second Quarter Results
5. Solta Medical Reports First Quarter Results
6. Solta Medical to Present at the JMP Securities Research Conference
7. Solta Medical Announces First Quarter 2011 Results Release and Conference Call
8. Solta Medical Reports Fourth Quarter and Full Year 2010 Results
9. Solta Medical Announces Full Year and Fourth Quarter 2010 Results Release and Conference Call
10. Solta Medical, Inc. Appoints Thomas J. Yorkey, Ph.D. to Vice President of Research & Development
11. Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices